申请人:Taivex Therapeutics Corporation
                            
                            
                                公开号:US08999983B2
                            
                            
                                公开(公告)日:2015-04-07
                            
                            
Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Such compounds disrupt Nek2/Hec1 binding and may be useful as chemotherapeutic agents for neoplastic diseases.
                            提供了调节Hec1/Nek2相互作用的化合物、组合物和方法。这些化合物破坏Nek2/Hec1结合,可能作为治疗肿瘤疾病的化疗药物有用。